$1.90
-0.18-8.65%
At close: -
$1.95
0.052.63%
After Hours: Dec 20, 7:09 PM EDT
Comments
Loading...
BioVie (NASDAQ:BIVI) Stock Quotes, Forecast and News Summary
BioVie Stock (NASDAQ: BIVI) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioVie (BIVI) stock?
You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.
Who are BioVie (BIVI) competitors?
Other companies in BioVie’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), Barinthus Biotherapeutics (NASDAQ:BRNS) and FibroGen (NASDAQ:FGEN).
What is the forecast, or price target, for BioVie (BIVI) stock?
BioVie has a consensus price target of $6.75.
What is the current price for BioVie (BIVI)?
The stock price for BioVie (NASDAQ: BIVI) is $1.9499 last updated December 20, 2024 at 7:09 PM EST.
Does BioVie (BIVI) pay a dividend?
There are no upcoming dividends for BioVie.
When is BioVie (NASDAQ:BIVI) reporting earnings?
BioVie’s Q2 earnings are confirmed for Tuesday, February 11, 2025.
Is BioVie (BIVI) going to split?
There is no upcoming split for BioVie.
What sector and industry does BioVie (BIVI) operate in?
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.